Hypocretin and GABA interact in the pontine reticular formation to increase wakefulness

Sleep

Volumn 33, Issue 10, 2010, Pages 1285-1293

  Brevig, Holly N ^a   Watson, Christopher J ^a   Lydic, Ralph ^a   Baghdoyan, Helen A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Bicuculline; Microinjection; Orexin; SB 334867

Indexed keywords

1 (2 METHYL 6 BENZOXAZOLYL) 3 (1,5 NAPHTHYRIDIN 4 YL)UREA; BICUCULLINE; OREXIN 1 RECEPTOR; OREXIN A; RINGER SOLUTION;

ADULT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROMYOGRAM; GABAERGIC TRANSMISSION; HUMAN; MALE; MICROINJECTION; NONHUMAN; NONREM SLEEP; PONS RETICULAR FORMATION; PRIORITY JOURNAL; RAT; REM SLEEP; WAKEFULNESS;

EID: 77956856103     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/33.10.1285     Document Type: Article

References (58)

1. Peyron C, Tighe DK, van den Pol AN, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci 1998;18:9996-10015. (Pubitemid 28543775)
2. Sakurai T, Amemiya A, Ishii M, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell 1998;92:573-85.
3. de Lecea L, Kilduff TS, Peyron C, et al. The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity. Proc Natl Acad Sci U S A 1998;95:322-7.
4. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
5. Thannickal TC, Moore RY, Nienhuis R, et al. Reduced number of hypocretin neurons in human narcolepsy. Neuron 2000;27:469-74.
6. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999;98:437-51.
7. Gerashchenko D, Kohls MD, Greco M, et al. Hypocretin-2-saporin lesions of the lateral hypothalamus produce narcoleptic-like sleep behavior in the rat. J Neurosci 2001;21:7273-83. (Pubitemid 32846974)
8. Beuckmann CT, Sinton CM, Williams SC, et al. Expression of a polyglutamine-ataxin-3 transgene in orexin neurons induces narcolepsy-cataplexy in the rat. J Neurosci 2004;24:4469-77.
9. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999;98:365-76.
10. Nuñez A, Moreno-Balandrán ME, Rodrigo-Angulo ML, Garzón M, De Andrés I. Relationship between the perifornical hypothalamic area and oral pontine reticular nucleus in the rat. Possible implication of the hypocretinergic projection in the control of rapid eye movement sleep. Eur J Neurosci 2006;24:2834-42.
11. th ed. London: Elsevier Press; 2007.
12. Lydic R, Baghdoyan HA. Sleep, anesthesiology, and the neurobiology of arousal state control. Anesthesiology 2005;103:1268-95.
13. Watson CJ, Soto-Calderon H, Lydic R, Baghdoyan HA. Pontine reticular formation (PnO) administration of hypocretin-1 increases PnO GABA levels and wakefulness. Sleep 2008;31:453-64. (Pubitemid 351694267)
14. Xi MC, Fung SJ, Yamuy J, Morales FR, Chase MH. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat. J Neurophysiol 2002;87:2880-8.
15. Moreno-Balandrán E, Garzón M, Bodaló C, Reinoso-Suárez F, de Andrés I. Sleep-wakefulness effects after microinjections of hypocretin 1 (orexin A) in cholinoceptive areas of the cat oral pontine tegmentum. Eur J Neurosci 2008;28:331-41.
16. Xi M, Chase M. Hypocretin induces either active (REM) sleep or wakefulness depending on the state of the animal at the time of administration. Sleep 2009;32 (Abstract Suppl):0012.
17. Bernard R, Lydic R, Baghdoyan HA. Hypocretin (orexin) receptor subtypes differentially enhance acetylcholine release and activate G protein subtypes in rat pontine reticular formation. J Pharmacol Exp Ther 2006;317:163-71.
18. Brown RE, McKenna JT, Winston S, et al. Characterization of GABAergic neurons in rapid-eye-movement sleep controlling regions of the brain-stem reticular formation in GAD67-green fluorescent protein knock-in mice. Eur J Neurosci 2008;27:352-63.
19. Camacho-Arroyo I, Alvarado R, Manjarrez J, Tapia R. Microinjections of muscimol and bicuculline into the pontine reticular formation modify the sleep-waking cycle in the rat. Neurosci Lett 1991;129:95-7.
20. A receptor antagonist bicuculline into the pontine reticular formation of C57BL/6J mouse decreases wakefulness and increases sleep. Sleep 2006;29 (Abstr Suppl):0022.
21. A receptor agonist muscimol into the pontine reticular nucleus, oral part (PnO) of C57BL/6J (B6) mouse causes a concentration dependent increase in wakefulness and decrease in sleep. Neuroscience Meeting Planner Online 2007;Program No. 631.5
22. Marks GA, Sachs OW, Birabil CG. Blockade of GABA, type A, receptors in the rat pontine reticular formation induces rapid eye movement sleep that is dependent upon the cholinergic system. Neuroscience 2008;156:1-10.
23. Sanford LD, Tang X, Xiao J, Ross RJ, Morrison AR. GABAergic regulation of REM sleep in reticularis pontis oralis and caudalis in rats. J Neurophysiol 2003;90:938-45.
24. Vanini G, Watson CJ, Lydic R, Baghdoyan HA. GABA-mediated neurotransmission in the pontine reticular formation modulates hypnosis, immobility, and breathing during isoflurane anesthesia. Anesthesiology 2008;109:978-88.
25. Xi MC, Morales FR, Chase MH. Evidence that wakefulness and REM sleep are controlled by a GABAergic pontine mechanism. J Neurophysiol 1999;82:2015-9.
26. Brevig HN, Watson CJ, Lydic R, Baghdoyan HA. The hypocretin-1 (hcrt-1)-induced increase in wakefulness and decrease in sleep is blocked by bicuculline or the hypocretin receptor-1 (hcrt-r1) antagonist SB-334867. Neuroscience Meeting Planner Online 2008;Program Number 285.14
27. Brevig HN, Watson CJ, Lydic R, Baghdoyan HA. Hypocretin-1 microinjected into the pontine reticular nucleus, oral part (PnO) of Sprague Dawley rat causes a concentration dependent increase in wakefulness and decrease in sleep. Sleep 2009;32 (Abstr Suppl):0018.
28. Watson CJ, Lydic R, Baghdoyan HA. Sleep and GABA levels in the oral part of rat pontine reticular formation are decreased by local and systemic administration of morphine. Neuroscience 2007;144:375-86. (Pubitemid 44841996)
29. Opp MR. Rat strain differences suggest a role for corticotropin-releasing hormone in modulating sleep. Physiol Behav 1998;63:67-74.
30. Ohno K, Sakurai T. Orexin neuronal circuitry: role in the regulation of sleep and wakefulness. Front Neuroendocrinol 2008;29:70-87.
31. Steriade M, McCarley RW. Brainstem Control of Wakefulness and Sleep. 2nd ed. New York: Kluwer Academic/Plenum Press, 2005.
32. Norman J. Drug-receptor reactions. Br J Anaesth 1979;51:595-601.
33. 1 receptor agonist microinjected into the pontine reticular formation of Sprague Dawley rat. J Pain 2010;11:535-44.
34. Kshatri AM, Baghdoyan HA, Lydic R. Cholinomimetics, but not morphine, increase antinociceptive behavior from pontine reticular regions regulating rapid-eye-movement sleep. Sleep 1998;21:677-85.
35. Wang W, Baghdoyan HA, Lydic R. Leptin replacement restores supraspinal cholinergic antinociception in leptin deficient obese mice. J Pain 2009;10:836-43.
36. Tsujino N, Sakurai T. Orexin/hypocretin: a neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009;61:162-76.
37. Vanini G, Lydic R, Baghdoyan HA. GABAergic modulation of REM sleep. In: Mallick BN, Pandi-Perumal SR, McCarley RW, Morrison AR, eds. Rapid Eye Movement Sleep - Regulation and Function. New York, NY: Cambridge University Press; 2010:in press.
38. Vanini G, Wathen BL, Lydic R, Baghdoyan HA. GABA levels in cat pontine reticular formation (PRF) are lower during rapid eye movement (REM) sleep and the neostigmine-induced REM sleep-like state (REMNeo) than during wakefulness. Sleep 2009;32 (Abstr Suppl):0011.
39. Kelz MB, Sun Y, Chen J, et al. An essential role for orexins in emergence from general anesthesia. Proc Natl Acad Sci U S A 2008;105:1309-14.
40. A receptors in the physiology and pharmacology of sleep. Eur J Neurosci 2009;29:1779-94.
41. Franks NP. General anaesthesia: from molecular targets to neuronal pathways of sleep and arousal. Nat Rev Neurosci 2008;9:370-86.
42. A receptor-mediated responses in pedunculopontine neurons. Sleep 2009;32:879-87.
43. Lin JS, Sakai K, Vanni-Mercier G, Jouvet M. A critical role of the posterior hypothalamus in the mechanisms of wakefulness determined by microinjection of muscimol in freely moving cats. Brain Res 1989;479:225-40. (Pubitemid 19035906)
44. Tsuchiya T, Fukushima H. Effects of benzodiazepines on PGO firings and multiple unit activity in the midbrain reticular formation in cats. Electroencephalogr Clin Neurophysiol 1977;43:700-6.
45. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Ann Neurol 2003;53:154-66.
46. Taheri S, Zeiter JM, Mignot E. The role of hypocretins (orexins) in sleep regulation and narcolepsy. Annu Rev Neurosci 2002;25:283-313.
47. Mochizuki T, Crocker A, McCormack S, Yanagisawa M, Sakai K, Scammell TE. Behavioral state instability in orexin knock-out mice. J Neurosci 2004;24:649-63.
48. Zhang S, Zeitzer JM, Sakurai T, Nishino S, Mignot E. Sleep/wake fragmentation disrupts metabolism in a mouse model of narcolepsy. J Physiol 2007;581:649-63. (Pubitemid 46831762)
49. Diniz Behn CG, Kopell N, Brown EN, Mochizuki T, Scammell TE. Delayed orexin signaling consolidates wakefulness and sleep: physiology and modeling. J Neurophysiol 2008;99:3090-103.
50. Xi M, Fung SJ, Yamuy J, Morales FR, Chase MH. Induction of active (REM) sleep and motor inhibition by hypocretin in the nucleus pontis oralis of the cat. J Neurophysiol 2002;87:2880-8.
51. A receptors inhibit acetylcholine release in cat pontine reticular formation: implications for REM sleep regulation. J Neurophysiol 2004;92:2198-206.
52. Lydic R, Baghdoyan HA. Acetylcholine modulates sleep and wakefulness: a synaptic perspective. In: Monti JM, Pandi-Perumal SR, Sinton CM, eds. Neurochemistry of Sleep and Wakefulness. New York, NY: Cambridge University Press; 2008:109-43.
53. Greco MA, Shiromani PJ. Hypocretin receptor protein and mRNA expression in the dorsolateral pons of rats. Brain Res Mol Brain Res 2001;88:176-82.
54. Brischoux F, Mainville L, Jones BE. Muscarinic-2 and orexin-2 receptors on GABAergic and other neurons in the rat mesopontine tegmentum and their potential role in sleep-wake state control. J Comp Neurol 2008;510:607-30.
55. 2C receptor involvement. Psychopharmacology (Berl) 2001;153:203-9.
56. Bingham S, Davey PT, Babbs AJ, et al. Orexin-A, an hypothalamic peptide with analgesic properties. Pain 2001;92:81-90.
57. Lydic R, Baghdoyan HA. Neurochemical mechanisms mediating opioid-induced REM sleep disruption. In: Lavigne G, Sessle BJ, Choiniere M, Soja PJ, eds. Sleep and Pain. Seattle, WA: IASP Press; 2007:99-122.
58. Zeilhofer HU, Mohler H, Lio AD. GABAergic analgesia: new insights from mutant mice and subtype-selective agonists. Trends Pharmacol Sci 2009;30:397-402.